News

Drug Delivery Business
drugdeliverybusiness. com > ascensia-launches-new-insulin-pen-needles

Ascensia launches new insulin pen needles

4+ hour, 2+ min ago  (196+ words) June 1, 2026 By Sean Whooley The Basel, Switzerland-based company said the launch further strengthens its Contour portfolio with a solution that improves the everyday injection experience. It marks the company's entry into the pen needle category. Ascensia designed Contour Comfort pen…...

Symbols: btc-usd
Drug Delivery Business
drugdeliverybusiness. com > mylife-manufacturing-responsibility-insulin-pumps

My Life takes on manufacturing responsibility for insulin pumps

2+ hour, 39+ min ago  (246+ words) June 1, 2026 By Sean Whooley Burgdorf, Switzerland-based My Life says it has now become the legal manufacturer for My Life products, as of today, June 1, 2026. It plans to introduce products under the new legal manufacturer to the market in a step-by-step…...

Symbols: btc-usd
Google News
drugdeliverybusiness. com > vicentra-triples-manufacturing-capacity-kaleido-rollout

Vi Centra triples manufacturing capacity ahead of Kaleido rollout

4+ day, 7+ hour ago  (412+ words) May 28, 2026 By Sean Whooley The Dutch automated insulin delivery system developer said it began production of consumables, including infusion sets and insulin cartridges, with the Molex company " a leading global medical technology contract development and manufacturing organization (CDMO). The collaboration…...

Symbols: btc-usd
Drug Delivery Business
drugdeliverybusiness. com > glucotrack-ceo-explains-tech-cbgm-implant

Glucotrack CEO explains tech behind long-term CBGM implant

5+ day, 6+ hour ago  (599+ words) May 27, 2026 By Sean Whooley Glucotrack (Nasdaq: GCTK) has made great strides over the past several years as it advances its implantable continuous blood glucose monitor (CBGM). After the company completed the first-in-human study'of the system, it shared findings from that…...

Symbols: nasdaq:gctk
Drug Delivery Business
drugdeliverybusiness. com > tandem-launches-tslim-mobile-app-european-countries

Tandem launches t: slim mobile app in trio of European countries

6+ day, 1+ hour ago  (243+ words) May 26, 2026 By Sean Whooley The company said on Linked In via its International account that it made the app available on both Android and i OS in Germany, Belgium and the Netherlands. San Diego-based Tandem's t: slim mobile app connects to…...

Symbols: nasdaq:tndm
Drug Delivery Business
drugdeliverybusiness. com > beta-bionics-q2-2027-mint-launch

Beta Bionics earmarks Q2 2027 for Mint patch pump launch

1+ week, 3+ day ago  (471+ words) May 21, 2026 By Sean Whooley Irvine, California-based Beta Bionics said it expects to fully commercialize Mint by the end of the second quarter of 2027. This represents an accelerated timeline compared to previous expectations for the end of 2027. The automated insulin delivery…...

Symbols: nasdaq:bbnx
Drug Delivery Business
drugdeliverybusiness. com > tandem-diabetes-care-terminates-cco

Tandem Diabetes Care terminates chief commercial officer

1+ week, 6+ day ago  (256+ words) May 18, 2026 By Sean Whooley The SEC Form 8-K, filed on May 15, says that the company notified Novara, an EVP in addition to serving as CCO, on May 11 that his employment was being terminated without cause. The San Diego-based automated insulin…...

Symbols: nasdaq:tndm
Google News
drugdeliverybusiness. com > embecta-completes-owen-mumford-acquisition

Embecta completes Owen Mumford acquisition

1+ week, 6+ day ago  (252+ words) May 18, 2026 By Sean Whooley Embecta (Nasdaq: EMBC) announced that it completed its previously announced acquisition of Owen Mumford Holdings Limited. Parsippany, New Jersey-based Embecta completed the deal on Friday, May 15. The former BD Diabetes business agreed to acquire Owen Mumford…...

Symbols: nasdaq:embc
Drug Delivery Business
drugdeliverybusiness. com > dexcom-launches-flex-cgm-type-2-germany

Dexcom launches Flex CGM for type 2 diabetes in Germany

2+ week, 5+ hour ago  (263+ words) May 18, 2026 By Sean Whooley Flex targets adults with type 2 not on intensive insulin therapy, providing an option for those on basal insulin, oral medications or GLP-1 receptor agonists. San Diego-based Dexcom says its new system, set to roll out in…...

Symbols: nasdaq:gctk
Drug Delivery Business
drugdeliverybusiness. com > dexcom-unveils-next-gen-g8-cgm

Dexcom unveils next-gen G8 CGM system

2+ week, 3+ day ago  (597+ words) May 14, 2026 By Sean Whooley San Diego-based Dexcom CEO Jake Leach previously told'Drug Delivery Business News that the G8 would offer a "much smaller wearable" in a step-change from the company's current-generation G7 system. At the company's investor day, Leach offered more insight…...

Symbols: nasdaq:dxcm